FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy

The SenSight™ Directional Lead System Was Designed to Enable Precision, Personalization and Enhanced Patient Comfort DUBLIN, June 7, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, to... Devices, Neurology, FDA Medtronic, SenSight, Directional Lead, Deep Brain Stimulation, neuromodulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news